Connecticut Analytical Corporation (CAC) is a medical instrument manufacturing firm whose activities have since expanded to include instrument design, applied research and medical diagnostic investigation. The firms scientific team was headed by the late Dr. John Fenn, the 2002 winner of the Nobel Prize in Chemistry. CAC rapidly transforms theoretical research into tangible, field qualified products for industrial, homeland security, nanotechnology, and biomedical applications. The firm is divided into five divisions: CAC Diagnostics, CAC Research, CAC Instruments, CAC Counter-Terrorism, CAC Legal Technical Support Servcies. The firm designs and manufactures a variety of gas detectors and monitors for specialized medical applications such as Magnetic Resonance Imaging (MRI) machines. CAC's OxySense 1000 O2 monitor series offers an accurate and simple method to determine ambient oxygen concentrations in work environments. OxySense monitors provide an invaluable means of continuous ambient oxygen level monitoring capability and assuring prompt worker notification of potentially harmful oxygen deficient environments. CAC also works in the field of counter-terrorism in order to provide both anti-terror and counter-terror solutions to government and private industries. Other areas of interest to CAC include: Red Cell analysis; Custom novel tracking-tagging technology; Chemical-biological-radioactive detection devices; Armed and Unarmed security personnel for both in and out CONUS; Middle East security support (former SEALs, DELTA, Rangers); Detection for nuclear reactors, chemical and oil facilities, dams & other high value targets
